AbCellera Biologics Insider Trades

ABCL

Track insider trading activity from AbCellera Biologics executives and directors. See which insiders are buying and selling ABCL stock.

Trades Last 12 Months

All Insider Trades for AbCellera Biologics

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Hayden Michael R Director
Holding Value $16.9M 1,373,397 shares
Last Trade
Aug 24, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$570k 53,613 shares
$10.64
$12.27
Holding Value $3.08M 251,000 shares
Last Trade
Aug 18, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$110k 10,000 shares
$11.03
$12.27
Booth Andrew Chief Financial Officer
Holding Value $5.92M 482,800 shares
Last Trade
Aug 14, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$384k 37,200 shares
$10.32
$12.27
Sandor Victor Director
Holding Value $1.87M 152,207 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 152,207 shares
$7.85
$12.27
Seely Lynn Director
Holding Value $1.87M 152,207 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 152,207 shares
$7.85
$12.27
Quake Stephen Director
Holding Value $3.76M 306,633 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$589k 111,701 shares
$5.27
$12.27
Holding Value $689M 56,134,097 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$131k 38,000 shares
$3.44
$12.27
Hansen Carl L. G. 10% owner, Chief Executive Officer
Holding Value $161M 13,096,837 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.2M 2,106,505 shares
$3.42
$12.27
Lecault Veronique Chief Technology Officer
Holding Value $63.8M 5,201,069 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 539,265 shares
$3.42
$12.27
Stimart Tryn Chief Legal Officer
Holding Value $57M 4,646,012 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 539,265 shares
$3.42
$12.27
Lo Andrew Director
Holding Value $6.64M 541,354 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$752k 238,864 shares
$3.15
$12.27
Hamer John Director
Holding Value $1.58M 128,862 shares
Last Trade
Sep 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.33M 137,351 shares
$16.93
$12.27
Falconer Ester Chief Technology Officer
Holding Value $10.7M 875,000 shares
Last Trade
Sep 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.8M 875,000 shares
$16.93
$12.27
Dcvc Bio, L.P. 10% owner
Holding Value $296M 24,105,761 shares
Last Trade
Jun 18, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$116M 5,000,000 shares
$23.19
$12.27
Thiel Peter Director
Holding Value $41M 3,343,240 shares
Last Trade
Dec 15, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$157M 3,343,240 shares
$46.99
$12.27

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up